Peptide Protocol
Peptide Protocol
App Store

BPC-157 vs TB-500: the honest comparison

They are complementary, not competitive — most serious recovery protocols run both. BPC-157 is the local-healing specialist; TB-500 is the systemic-migration specialist. If you have to pick one, pick BPC-157 for targeted tissue injuries and TB-500 for full-body wear.

Key differenceBPC-157 acts locally around the injection site and on gastric tissue; TB-500 acts systemically via G-actin binding and angiogenesis. Different mechanisms, different scopes, which is why they pair rather than compete.
Can you stack?Yes — BPC-157 + TB-500 is the single most common healing stack. They address different mechanisms (local tissue-repair modulation vs systemic cell migration) and are widely run together for weeks at a time. See the full BPC-157 + TB-500 stack guide for cadence and dosing notes.
TagsHealing Soft tissue

Side-by-side facts

BPC-157TB-500
ClassGastric pentadecapeptide (15 amino acids)Synthetic peptide fragment of thymosin beta-4
Half-lifeOral form ~4 hours; subcutaneous estimated 4–6 hoursApproximately 2 hours (peptide); biological effect lasts longer
Typical dose200–500 mcg per injection, 1–2x daily2–5 mg (2000–5000 mcg) per injection, 1–2x weekly loading, then maintenance
CategoryHealing / tissue repairHealing / tissue repair
FDA statusNot FDA approved. Research use only in the US. Removed from FDA 503A bulks list in 2023.Not FDA approved. Research use only in the US.
StorageLyophilized: room temp (stable, short term) or refrigerated.Lyophilized stable at room temp.

What they have in common

Both are research peptides with strong animal-model evidence for soft-tissue healing, both are unapproved for human use in the US, and both are commonly stacked together in injury-recovery protocols.

When to pick BPC-157

Pick BPC-157 for a specific injury — tendon, ligament, localized muscle strain, GI inflammation — where the pathology sits in one place. BPC-157's effect is strongest around the injection site and on gastric tissue regardless of injection site.

When to pick TB-500

Pick TB-500 when the problem is systemic or distributed — generalized soft-tissue wear, overuse syndromes, post-surgical whole-body recovery. TB-500's action on cell migration and VEGF is systemic; it reaches every tissue rather than acting locally.

Can you stack them?

Yes — BPC-157 + TB-500 is the single most common healing stack. They address different mechanisms (local tissue-repair modulation vs systemic cell migration) and are widely run together for weeks at a time. See the full BPC-157 + TB-500 stack guide for cadence and dosing notes.

They stack → See our full BPC-157 + TB-500 stack guide for cadence and side-effect notes.

The two compounds

Track either compound on iPhone

Peptide Protocol schedules doses, calculates reconstitution, and logs side effects for both — on iPhone, free to download.

See the app →

Frequently asked questions

What is the main difference between BPC-157 and TB-500?

BPC-157 acts locally around the injection site and on gastric tissue; TB-500 acts systemically via G-actin binding and angiogenesis. Different mechanisms, different scopes, which is why they pair rather than compete.

Can you stack BPC-157 and TB-500?

Yes — BPC-157 + TB-500 is the single most common healing stack. They address different mechanisms (local tissue-repair modulation vs systemic cell migration) and are widely run together for weeks at a time. See the full BPC-157 + TB-500 stack guide for cadence and dosing notes.

Which is better, BPC-157 or TB-500?

They are complementary, not competitive — most serious recovery protocols run both. BPC-157 is the local-healing specialist; TB-500 is the systemic-migration specialist. If you have to pick one, pick BPC-157 for targeted tissue injuries and TB-500 for full-body wear.

When should I pick BPC-157?

Pick BPC-157 for a specific injury — tendon, ligament, localized muscle strain, GI inflammation — where the pathology sits in one place. BPC-157's effect is strongest around the injection site and on gastric tissue regardless of injection site.

When should I pick TB-500?

Pick TB-500 when the problem is systemic or distributed — generalized soft-tissue wear, overuse syndromes, post-surgical whole-body recovery. TB-500's action on cell migration and VEGF is systemic; it reaches every tissue rather than acting locally.

Are BPC-157 and TB-500 FDA approved?

BPC-157: Not FDA approved. Research use only in the US. Removed from FDA 503A bulks list in 2023. — TB-500: Not FDA approved. Research use only in the US.

Educational use only. Peptide Protocol is an informational tool. Nothing on this page constitutes medical advice. Many peptides are prescription-only or restricted in your jurisdiction. Always consult a licensed healthcare professional before injecting any compound.